As a proof of concept, a previous study showed that inhibition of caveolin-1 signalling by siRNA or caveolin scaffolding peptide in inflammatory breast cancer cells resulted in a reduction in invasive potential in an Akt1-dependent manner [46]. The gene discussed is AKT1; the disease is breast carcinoma.